Vontobel Holding
LEXX icon

Vontobel Holding’s Lexaria Bioscience LEXX Stock Holding History

Vontobel Holding’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.9K Buy
+23,000
New +$16.7K ﹤0.01% 1185

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return

Vontobel Holding's LEXX Position: Q1 2026 in Review

Vontobel Holding opened a new position in Lexaria Bioscience (LEXX) in Q1 2026: 23,000 shares worth $17.9K. The stake represents ﹤0.01% of the portfolio and ranks #1185 among its holdings.

28 funds tracked by Wall St. Rank hold LEXX as of Q1 2026.

  • Vontobel Holding held 23,000 shares of Lexaria Bioscience worth $17.9K as of Q1 2026.
  • Lexaria Bioscience was a new Vontobel Holding position in Q1 2026.
  • Lexaria Bioscience made up ﹤0.01% of Vontobel Holding's portfolio in Q1 2026, its #1185 holding.
  • 28 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.